A proof-of-concept study to evaluate the antiinflammatory effects of a novel soluble cyclodextrin formulation of nebulized budesonide in patients with mild to moderate asthma.

Williamson, Peter A; Menzies, Daniel; Nair, Arun; Tutuncu, Ahmet; Lipworth, Brian J

Williamson, Peter A; Menzies, Daniel; Nair, Arun; Tutuncu, Ahmet; Lipworth, Brian J.

Affiliation

Williamson PA; Asthma and Allergy Research Group, University of Dundee, Dundee, Scotland. p.a.williamson@dundee.ac.uk

Ann Allergy Asthma Immunol ; 102(2): 161-7, 2009 Feb.

Article in En | MEDLINE | ID: mdl-19230469

Subject(s)

Anti-Inflammatory Agents/therapeutic use; Asthma/drug therapy; Budesonide/therapeutic use; Cyclodextrins/therapeutic use; Adult; Dosage Forms; Female; Humans; Male; Middle Aged; Severity of Illness Index; Solubility; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Budesonide / Cyclodextrins / Anti-Inflammatory Agents Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Ann Allergy Asthma Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2009 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google